Monte Rosa Therapeutics Inc (GLUE)

Investing Cash Flow

-$316.79M

TTM · Period ending: · USD

GLUE logo

GLUE Investing Cash Flow

Latest reported-$316.79M
GLUE TTM Cash from Investing (-$3.39M → -$316.79M)
High-resolution chart · PNG

GLUE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Monte Rosa Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-316,785,000
-262,601,000
-101,833,000
-67,663,000
-68,052,000
-154,534,000
-44,452,000
741,000
-1,380,000
78,328,000
88,801,000
20,565,000
14,426,000
-18,373,000
-219,219,000
-168,327,000
-199,504,000
-187,956,000
-9,653,000
-7,792,000
-7,034,000
-5,593,000
-3,389,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.